Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03248973
Other study ID # 106030-C
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 3, 2017
Est. completion date February 2, 2018

Study information

Verified date February 2019
Source Far Eastern Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Successful Treatment of Maternal Listeria Monocytogenes Bacteremia in the First Trimester of Pregnancy


Description:

A 34-year-old nulliparous woman with 11 gestational weeks with flu-like illness was proved to be infection by Listeria monocytogenes, and then treated by intravenous ampicillin 2 g every 4 hours for 3 weeks. A healthy unaffected male baby was delivered at 41 weeks' gestation.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date February 2, 2018
Est. primary completion date January 8, 2018
Accepts healthy volunteers No
Gender Female
Age group 20 Years and older
Eligibility Inclusion Criteria:

- One pregnant woman with listeria monocytogenes bacteremia in the first trimester

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ampicillin Injection
Ampicillin injection 2 g q4h for 3 weeks

Locations

Country Name City State
Taiwan Far Eastern Memorial Hospital New Taipei

Sponsors (1)

Lead Sponsor Collaborator
Far Eastern Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Successful treatment A favorable outcome of maternal listeria infection in the first trimester may be anticipated. Besides, intravenous ampicillin with or without gentamicin should be a reasonable treatment option for maternal listeria infection in the first trimester. 1 month after delivery